Diagnostic and Therapeutic Advances in Eosinophilic Esophagitis

Program Date: 7 September 2019
Publication Date: 16 January 2020
Continuing Education Units: Nurse Contact: 1.0; Dietitian CPEU: 1.0

Course Description:

In this course, you’ll discuss diagnostic advances, including the new international consensus diagnostic guidelines; discuss the rationale and approach to dietary elimination therapy; review pharmacologic treatments for EoE; and more.

Course Objectives:

•Discuss diagnostic advances, including the new international consensus diagnostic guidelines.
•Discuss the rationale and approach to dietary elimination therapy, less restrictive strategies for dietary elimination, and novel approaches to identifying dietary triggers.
•Provide an overview of pharmacologic treatments for EoE.
•Present an overall treatment algorithm for EoE.
  • CDR Level: 2
  • Suggested Learning Codes: 5000, 5070, 5110, 5410
  • Performance Indicators: 4.1.2, 8.1.5, 8.3.1, 8.3.6
  • Run Time: 48

Course Instructor Bio(s)

Headshot placeholder

Evan S. Dellon, MD, MPH

Professor, Medicine and Epidemiology
Center for Esophageal Diseases and Swallowing
Division of Gastroenterology and Hepatology
University of North Carolina School of Medicine Chapel Hill, NC, USA

Evan S. Dellon, MD, MPH, is a Professor of Medicine and Adjunct Associate Professor of Epidemiology at the University of North Carolina School of Medicine in Chapel Hill. Dr. Dellon received his undergraduate degree from Brown University and his medical degree from Johns Hopkins School of Medicine. He completed internship and residency in Internal Medicine at Massachusetts General Hospital. He performed a clinical and a research fellowship in Adult Gastroenterology at UNC, during which he also received a Master of Public Health degree in Epidemiology from the UNC School of Public Health. Dr. Dellon joined the UNC faculty and the Center for Esophageal Diseases and Swallowing (CEDAS) in 2008, where his main clinical focus is on disorders of swallowing, and in particular eosinophilic esophagitis (EoE). He became Director of CEDAS in 2014 and is an Associate Editor for Clinical Gastroenterology and Hepatology.

Dr. Dellon’s main research interest is in the epidemiology, pathogenesis, diagnosis, treatment, and outcomes of eosinophilic esophagitis (EoE) and the eosinophilic GI diseases (EGIDs). The goal of his research is to improve the lives of patients with EoE and EGIDs by learning how to better diagnose, treat, and monitor the condition. He is widely published in this area and collaborates with investigators all over the world. Dr. Dellon has received research funding from the National Institutes of Health, the American College of Gastroenterology, the American Gastroenterologic Association, the CURED Foundation, UNC, and several industry partners to study EoE and other EGIDs.

enroll.svg
ENROLL NOW

You Must LOG IN to Enroll

certificate-icon

attended a live program?

question-marks

FREQUENTLY ASKED QUESTIONS

medical-education

continuing medical education courses

Earn CME credits at no cost to you.